Skip to main content

Human Papillomavirus: Vaccination

Question for Department of Health and Social Care

UIN 73853, tabled on 12 November 2021

To ask the Secretary of State for Health and Social Care, what is his assessment of the impact of the covid-19 (a) outbreak and (b) vaccine rollout on the delivery of HPV vaccines in schools for 2021-22.

Answered on

17 November 2021

Routine childhood immunisation programmes continued to be delivered in primary care during the early stages of the pandemic. However, the closure of schools from 23 March 2020 disrupted the delivery of all school-aged immunisation programmes, including human papillomavirus (HPV).

Providers have adopted a flexible and transformative delivery model to address this and ensure that those who are eligible can receive their vaccinations. This includes prioritisation of immunisations based on the Joint Committee on Vaccination and Immunisation’s advice, digitalising consent processes and utilising a range of alternative community settings to deliver vaccines where appropriate. The Department of Health and Social Care and NHS England are working with the Department for Education to ensure that schools facilitate the continuation of vaccinations and improve uptake rates.

Providers are currently focussed on delivering the flu vaccine in schools as well as the COVID-19 vaccine. The prioritisation of the flu vaccine is usual for this time of year and school providers will recommence work on routine vaccinations and those outstanding in the new year.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.